Skip to content

TMS intervention study in patients with MDD

TMS intervention study in patients with MDD

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046458
Enrollment
Unknown
Registered
2021-05-16
Start date
2021-05-15
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression Disorder

Interventions

real TMS:real TMS
sham TMS:sham TMS

Sponsors

Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Meet ICD-10 criteria for MDD; 2.Baseline score of 17-item HAMD > 17; 3.Aged 12 to 18 years; 4.Right-handed; 5.Participants and their guardians sign the informed consent file.

Exclusion criteria

Exclusion criteria: 1.Exclude patients with other mental diseases other than current MDD; 2.Patients with depression caused by other systemic diseases and brain organic lesions were excluded; 3.Patients with a history of cranial diseases, imagination impairment, epileptic seizures, and other neurological diseases were excluded; 4.Patients with a history of serious systemic diseases such as cardiovascular system, respiratory system, and immune system were excluded; 5.Exclude patients with a history of alcohol and drug abuse; 6.Patients with metal implants such as dentures and pacemakers were excluded; 7.Women during pregnancy and lactation were excluded. 8.Patients receiving electroconvulsive therapy were excluded.

Design outcomes

Primary

MeasureTime frame
brain network connectivity;depression level;

Countries

China

Contacts

Public ContactXu Pengfei

Shenzhen University

xupf@szu.edu.cn+86 13811122158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026